Today, we examine how spatial omics and single-cell biology are overcoming the limitations of bulk sequencing by mapping gene activity directly within intact tissue architecture. Discover how this architectural shift is accelerating target discovery, refining biomarker validation, and powering the next generation of precision therapeutics.